LTA Antikörper (AA 1-205)
Kurzübersicht für LTA Antikörper (AA 1-205) (ABIN517575)
Target
Alle LTA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-205
-
Verwendungszweck
- Rabbit polyclonal antibody raised against a full-length human LTA protein.
-
Sequenz
- MTPPERLFLP RVRGTTLHLL LLGLLLVLLP GAQGLPGVGL TPSAAQTARQ HPKMHLAHST LKPAAHLIGD PSKQNSLLWR ANTDRAFLQD GFSLSNNSLL VPTSGIYFVY SQVVFSGKAY SPKATSSPLY LAHEVQLFSS QYPFHVPLLS SQKMVYPGLQ EPWLHSMYHG AAFQLTQGDQ LSTHTDGIPH LVLSPSTVFF GAFAL
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody reactive against mammalian transfected lysate.
-
Immunogen
- LTA (AAH34729.1, 1 a.a. ~ 205 a.a) full-length human protein.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Targeted inhibition of phosphatidyl inositol-3-kinase p110?, but not p110?, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers." in: Apoptosis : an international journal on programmed cell death, Vol. 18, Issue 4, pp. 509-20, (2013) (PubMed).
-
: "Targeted inhibition of phosphatidyl inositol-3-kinase p110?, but not p110?, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers." in: Apoptosis : an international journal on programmed cell death, Vol. 18, Issue 4, pp. 509-20, (2013) (PubMed).
-
- LTA (Lymphotoxin-alpha (LTA))
-
Andere Bezeichnung
- LTA
-
Substanzklasse
- Chemical
-
Hintergrund
-
Full Gene Name: lymphotoxin alpha (TNF superfamily, member 1)
Synonyms: LT,TNFB,TNFSF1 -
Gen-ID
- 4049
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-